Legal & General Group’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $20.9M | Buy |
139,072
+2,471
| +2% | +$269K | ﹤0.01% | 854 |
|
|
2026
Q1 | $12.6M | Sell |
136,601
-20,178
| -13% | -$2.03M | ﹤0.01% | 1020 |
|
|
2025
Q4 | $16M | Buy |
156,779
+5,174
| +3% | +$463K | ﹤0.01% | 937 |
|
|
2025
Q3 | $9.47M | Sell |
151,605
-6,464
| -4% | -$352K | ﹤0.01% | 1243 |
|
|
2025
Q2 | $8.23M | Sell |
158,069
-12,065
| -7% | -$539K | ﹤0.01% | 1292 |
|
|
2025
Q1 | $7.25M | Sell |
170,134
-7,053
| -4% | -$304K | ﹤0.01% | 1317 |
|
|
2024
Q4 | $5.41M | Sell |
177,187
-6,374
| -3% | -$179K | ﹤0.01% | 1538 |
|
|
2024
Q3 | $4.21M | Buy |
183,561
+12,510
| +7% | +$354K | ﹤0.01% | 1650 |
|
|
2024
Q2 | $4.94M | Sell |
171,051
-11,180
| -6% | -$260K | ﹤0.01% | 1533 |
|
|
2024
Q1 | $3.76M | Buy |
182,231
+22,536
| +14% | +$483K | ﹤0.01% | 1654 |
|
|
2023
Q4 | $4.32M | Sell |
159,695
-6,564
| -4% | -$172K | ﹤0.01% | 1592 |
|
|
2023
Q3 | $4.93M | Sell |
166,259
-10,791
| -6% | -$379K | ﹤0.01% | 1444 |
|
|
2023
Q2 | $6.34M | Buy |
177,050
+25,144
| +17% | +$722K | ﹤0.01% | 1322 |
|
|
2023
Q1 | $3.56M | Buy |
151,906
+32,550
| +27% | +$930K | ﹤0.01% | 1598 |
|
|
2022
Q4 | $3.25M | Sell |
119,356
-4,005
| -3% | -$183K | ﹤0.01% | 1637 |
|
|
2022
Q3 | $6.64M | Sell |
123,361
-16,550
| -12% | -$850K | ﹤0.01% | 1236 |
|
|
2022
Q2 | $5.64M | Buy |
139,911
+19,528
| +16% | +$968K | ﹤0.01% | 1349 |
|
|
2022
Q1 | $7.97M | Buy |
120,383
+11,007
| +10% | +$753K | ﹤0.01% | 1279 |
|
|
2021
Q4 | $10.9M | Buy |
109,376
+26,114
| +31% | +$2.7M | ﹤0.01% | 1163 |
|
|
2021
Q3 | $10.4M | Buy |
83,262
+18,243
| +28% | +$2.17M | ﹤0.01% | 1154 |
|
|
2021
Q2 | $8.07M | Buy |
65,019
+764
| +1% | +$103K | ﹤0.01% | 1291 |
|
|
2021
Q1 | $9.81M | Buy |
64,255
+5,464
| +9% | +$826K | ﹤0.01% | 1212 |
|
|
2020
Q4 | $7.58M | Sell |
58,791
-576
| -1% | -$66.3K | ﹤0.01% | 1264 |
|
|
2020
Q3 | $6.64M | Sell |
59,367
-249
| -0.4% | -$22.8K | ﹤0.01% | 1207 |
|
|
2020
Q2 | $4.84M | Buy |
59,616
+30,233
| +103% | +$2.44M | ﹤0.01% | 1322 |
|
|
2020
Q1 | $2.04M | Buy |
29,383
+522
| +2% | +$40.1K | ﹤0.01% | 1575 |
|
|
2019
Q4 | $2.25M | Buy |
28,861
+5,098
| +21% | +$367K | ﹤0.01% | 1746 |
|
|
2019
Q3 | $1.52M | Buy |
23,763
+4,482
| +23% | +$395K | ﹤0.01% | 1836 |
|
|
2019
Q2 | $1.66M | Buy |
19,281
+886
| +5% | +$67.7K | ﹤0.01% | 1779 |
|
|
2019
Q1 | $1.41M | Buy |
18,395
+16,141
| +716% | +$895K | ﹤0.01% | 1835 |
|
|
2018
Q4 | $85K | Buy |
+2,254
| New | +$83K | ﹤0.01% | 2502 |
|
Other funds holding GH
DTC
Legal & General Group's GH Position: Q2 2026 in Review
Legal & General Group increased its Guardant Health (GH) stake by 1.8% in Q2 2026, buying an estimated $269K and bringing the position to 139,072 shares worth $20.9M. The position accounts for ﹤0.01% of the portfolio, ranked #854.
Legal & General Group first reported a position in GH in Q4 2018 and has held it in 31 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.
- Legal & General Group held 139,072 shares of Guardant Health worth $20.9M as of Q2 2026.
- Legal & General Group bought 2,471 Guardant Health shares in Q2 2026, an estimated $269K.
- Guardant Health made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #854 holding.
- Legal & General Group first reported a position in Guardant Health in Q4 2018 and has held it in 31 quarters since.
- 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.
Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.